01.11.2001 | Original Paper
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2001
Einloggen, um Zugang zu erhalten